世界のクラッベ病治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Krabbe Disease Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3333 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、クラッベ病治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗けいれん薬、筋弛緩薬、その他）、用途別市場規模（病院、診療所、研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・クラッベ病治療薬の市場動向 ・企業の競争状況、市場シェア ・クラッベ病治療薬の種類別市場規模（抗けいれん薬、筋弛緩薬、その他） ・クラッベ病治療薬の用途別市場規模（病院、診療所、研究センター、その他） ・クラッベ病治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・クラッベ病治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・クラッベ病治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・クラッベ病治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・クラッベ病治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Johnson & Johnson、Novartis、Pfizer、Sanofi、Abbott Laboratories、Teva Pharmaceutical、Takeda、UCB Pharmaceuticals） ・結論

Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to make myelin in a human body.
Globally North America is the largest market for Krabbe disease treatment. Europe is the second-largest market and Asia Pacific is expected to grow at a fastest rate.

Market Analysis and Insights: Global Krabbe Disease Drugs Market
The global Krabbe Disease Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Krabbe Disease Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Krabbe Disease Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Krabbe Disease Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Krabbe Disease Drugs market.

Global Krabbe Disease Drugs Scope and Market Size
Krabbe Disease Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Krabbe Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anticonvulsants
Muscle Relaxants
Others

Segment by Application
Hospitals
Clinics
Research Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Johnson & Johnson
Novartis
Pfizer
Sanofi
Abbott Laboratories
Teva Pharmaceutical
Takeda
UCB Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Krabbe Disease Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anticonvulsants
1.2.3 Muscle Relaxants
1.2.4 Others
1.3 Market by Application
1.3.1 Global Krabbe Disease Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Krabbe Disease Drugs Market Perspective (2016-2027)
2.2 Krabbe Disease Drugs Growth Trends by Regions
2.2.1 Krabbe Disease Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Krabbe Disease Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Krabbe Disease Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Krabbe Disease Drugs Industry Dynamic
2.3.1 Krabbe Disease Drugs Market Trends
2.3.2 Krabbe Disease Drugs Market Drivers
2.3.3 Krabbe Disease Drugs Market Challenges
2.3.4 Krabbe Disease Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Krabbe Disease Drugs Players by Revenue
3.1.1 Global Top Krabbe Disease Drugs Players by Revenue (2016-2021)
3.1.2 Global Krabbe Disease Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Krabbe Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Krabbe Disease Drugs Revenue
3.4 Global Krabbe Disease Drugs Market Concentration Ratio
3.4.1 Global Krabbe Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Krabbe Disease Drugs Revenue in 2020
3.5 Krabbe Disease Drugs Key Players Head office and Area Served
3.6 Key Players Krabbe Disease Drugs Product Solution and Service
3.7 Date of Enter into Krabbe Disease Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Krabbe Disease Drugs Breakdown Data by Type
4.1 Global Krabbe Disease Drugs Historic Market Size by Type (2016-2021)
4.2 Global Krabbe Disease Drugs Forecasted Market Size by Type (2022-2027)

5 Krabbe Disease Drugs Breakdown Data by Application
5.1 Global Krabbe Disease Drugs Historic Market Size by Application (2016-2021)
5.2 Global Krabbe Disease Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Krabbe Disease Drugs Market Size (2016-2027)
6.2 North America Krabbe Disease Drugs Market Size by Type
6.2.1 North America Krabbe Disease Drugs Market Size by Type (2016-2021)
6.2.2 North America Krabbe Disease Drugs Market Size by Type (2022-2027)
6.2.3 North America Krabbe Disease Drugs Market Size by Type (2016-2027)
6.3 North America Krabbe Disease Drugs Market Size by Application
6.3.1 North America Krabbe Disease Drugs Market Size by Application (2016-2021)
6.3.2 North America Krabbe Disease Drugs Market Size by Application (2022-2027)
6.3.3 North America Krabbe Disease Drugs Market Size by Application (2016-2027)
6.4 North America Krabbe Disease Drugs Market Size by Country
6.4.1 North America Krabbe Disease Drugs Market Size by Country (2016-2021)
6.4.2 North America Krabbe Disease Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Krabbe Disease Drugs Market Size (2016-2027)
7.2 Europe Krabbe Disease Drugs Market Size by Type
7.2.1 Europe Krabbe Disease Drugs Market Size by Type (2016-2021)
7.2.2 Europe Krabbe Disease Drugs Market Size by Type (2022-2027)
7.2.3 Europe Krabbe Disease Drugs Market Size by Type (2016-2027)
7.3 Europe Krabbe Disease Drugs Market Size by Application
7.3.1 Europe Krabbe Disease Drugs Market Size by Application (2016-2021)
7.3.2 Europe Krabbe Disease Drugs Market Size by Application (2022-2027)
7.3.3 Europe Krabbe Disease Drugs Market Size by Application (2016-2027)
7.4 Europe Krabbe Disease Drugs Market Size by Country
7.4.1 Europe Krabbe Disease Drugs Market Size by Country (2016-2021)
7.4.2 Europe Krabbe Disease Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Krabbe Disease Drugs Market Size (2016-2027)
8.2 Asia-Pacific Krabbe Disease Drugs Market Size by Type
8.2.1 Asia-Pacific Krabbe Disease Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Krabbe Disease Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Krabbe Disease Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Krabbe Disease Drugs Market Size by Application
8.3.1 Asia-Pacific Krabbe Disease Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Krabbe Disease Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Krabbe Disease Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Krabbe Disease Drugs Market Size by Region
8.4.1 Asia-Pacific Krabbe Disease Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Krabbe Disease Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Krabbe Disease Drugs Market Size (2016-2027)
9.2 Latin America Krabbe Disease Drugs Market Size by Type
9.2.1 Latin America Krabbe Disease Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Krabbe Disease Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Krabbe Disease Drugs Market Size by Type (2016-2027)
9.3 Latin America Krabbe Disease Drugs Market Size by Application
9.3.1 Latin America Krabbe Disease Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Krabbe Disease Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Krabbe Disease Drugs Market Size by Application (2016-2027)
9.4 Latin America Krabbe Disease Drugs Market Size by Country
9.4.1 Latin America Krabbe Disease Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Krabbe Disease Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Krabbe Disease Drugs Market Size (2016-2027)
10.2 Middle East & Africa Krabbe Disease Drugs Market Size by Type
10.2.1 Middle East & Africa Krabbe Disease Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Krabbe Disease Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Krabbe Disease Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Krabbe Disease Drugs Market Size by Application
10.3.1 Middle East & Africa Krabbe Disease Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Krabbe Disease Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Krabbe Disease Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Krabbe Disease Drugs Market Size by Country
10.4.1 Middle East & Africa Krabbe Disease Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Krabbe Disease Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Krabbe Disease Drugs Introduction
11.1.4 GlaxoSmithKline Revenue in Krabbe Disease Drugs Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Krabbe Disease Drugs Introduction
11.2.4 Johnson & Johnson Revenue in Krabbe Disease Drugs Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Krabbe Disease Drugs Introduction
11.3.4 Novartis Revenue in Krabbe Disease Drugs Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Krabbe Disease Drugs Introduction
11.4.4 Pfizer Revenue in Krabbe Disease Drugs Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Krabbe Disease Drugs Introduction
11.5.4 Sanofi Revenue in Krabbe Disease Drugs Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Details
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Krabbe Disease Drugs Introduction
11.6.4 Abbott Laboratories Revenue in Krabbe Disease Drugs Business (2016-2021)
11.6.5 Abbott Laboratories Recent Development
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Details
11.7.2 Teva Pharmaceutical Business Overview
11.7.3 Teva Pharmaceutical Krabbe Disease Drugs Introduction
11.7.4 Teva Pharmaceutical Revenue in Krabbe Disease Drugs Business (2016-2021)
11.7.5 Teva Pharmaceutical Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Krabbe Disease Drugs Introduction
11.8.4 Takeda Revenue in Krabbe Disease Drugs Business (2016-2021)
11.8.5 Takeda Recent Development
11.9 UCB Pharmaceuticals
11.9.1 UCB Pharmaceuticals Company Details
11.9.2 UCB Pharmaceuticals Business Overview
11.9.3 UCB Pharmaceuticals Krabbe Disease Drugs Introduction
11.9.4 UCB Pharmaceuticals Revenue in Krabbe Disease Drugs Business (2016-2021)
11.9.5 UCB Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Krabbe Disease Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anticonvulsants
Table 3. Key Players of Muscle Relaxants
Table 4. Key Players of Others
Table 5. Global Krabbe Disease Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Krabbe Disease Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Krabbe Disease Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Krabbe Disease Drugs Market Share by Regions (2016-2021)
Table 9. Global Krabbe Disease Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Krabbe Disease Drugs Market Share by Regions (2022-2027)
Table 11. Krabbe Disease Drugs Market Trends
Table 12. Krabbe Disease Drugs Market Drivers
Table 13. Krabbe Disease Drugs Market Challenges
Table 14. Krabbe Disease Drugs Market Restraints
Table 15. Global Krabbe Disease Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Krabbe Disease Drugs Market Share by Players (2016-2021)
Table 17. Global Top Krabbe Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Krabbe Disease Drugs as of 2020)
Table 18. Ranking of Global Top Krabbe Disease Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Krabbe Disease Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Krabbe Disease Drugs Product Solution and Service
Table 22. Date of Enter into Krabbe Disease Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Krabbe Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Krabbe Disease Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Krabbe Disease Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Krabbe Disease Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Krabbe Disease Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Krabbe Disease Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Krabbe Disease Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Krabbe Disease Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Krabbe Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Krabbe Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Krabbe Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Krabbe Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Krabbe Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Krabbe Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Krabbe Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Krabbe Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Krabbe Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Krabbe Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Krabbe Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Krabbe Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Krabbe Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Krabbe Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Krabbe Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Krabbe Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Krabbe Disease Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Krabbe Disease Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Krabbe Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Krabbe Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Krabbe Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Krabbe Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Krabbe Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Krabbe Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Krabbe Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Krabbe Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Krabbe Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Krabbe Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Krabbe Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Krabbe Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Krabbe Disease Drugs Product
Table 65. GlaxoSmithKline Revenue in Krabbe Disease Drugs Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. Johnson & Johnson Company Details
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Krabbe Disease Drugs Product
Table 70. Johnson & Johnson Revenue in Krabbe Disease Drugs Business (2016-2021) & (US$ Million)
Table 71. Johnson & Johnson Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Krabbe Disease Drugs Product
Table 75. Novartis Revenue in Krabbe Disease Drugs Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Krabbe Disease Drugs Product
Table 80. Pfizer Revenue in Krabbe Disease Drugs Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Krabbe Disease Drugs Product
Table 85. Sanofi Revenue in Krabbe Disease Drugs Business (2016-2021) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Abbott Laboratories Company Details
Table 88. Abbott Laboratories Business Overview
Table 89. Abbott Laboratories Krabbe Disease Drugs Product
Table 90. Abbott Laboratories Revenue in Krabbe Disease Drugs Business (2016-2021) & (US$ Million)
Table 91. Abbott Laboratories Recent Development
Table 92. Teva Pharmaceutical Company Details
Table 93. Teva Pharmaceutical Business Overview
Table 94. Teva Pharmaceutical Krabbe Disease Drugs Product
Table 95. Teva Pharmaceutical Revenue in Krabbe Disease Drugs Business (2016-2021) & (US$ Million)
Table 96. Teva Pharmaceutical Recent Development
Table 97. Takeda Company Details
Table 98. Takeda Business Overview
Table 99. Takeda Revenue in Krabbe Disease Drugs Business (2016-2021) & (US$ Million)
Table 100. Takeda Recent Development
Table 101. UCB Pharmaceuticals Company Details
Table 102. UCB Pharmaceuticals Business Overview
Table 103. UCB Pharmaceuticals Krabbe Disease Drugs Product
Table 104. UCB Pharmaceuticals Revenue in Krabbe Disease Drugs Business (2016-2021) & (US$ Million)
Table 105. UCB Pharmaceuticals Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Krabbe Disease Drugs Market Share by Type: 2020 VS 2027
Figure 2. Anticonvulsants Features
Figure 3. Muscle Relaxants Features
Figure 4. Others Features
Figure 5. Global Krabbe Disease Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Krabbe Disease Drugs Report Years Considered
Figure 11. Global Krabbe Disease Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Krabbe Disease Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Krabbe Disease Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Krabbe Disease Drugs Market Share by Regions (2022-2027)
Figure 15. Global Krabbe Disease Drugs Market Share by Players in 2020
Figure 16. Global Top Krabbe Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Krabbe Disease Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Krabbe Disease Drugs Revenue in 2020
Figure 18. Global Krabbe Disease Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Krabbe Disease Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Krabbe Disease Drugs Market Share by Type (2016-2027)
Figure 22. North America Krabbe Disease Drugs Market Share by Application (2016-2027)
Figure 23. North America Krabbe Disease Drugs Market Share by Country (2016-2027)
Figure 24. United States Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Krabbe Disease Drugs Market Share by Type (2016-2027)
Figure 28. Europe Krabbe Disease Drugs Market Share by Application (2016-2027)
Figure 29. Europe Krabbe Disease Drugs Market Share by Country (2016-2027)
Figure 30. Germany Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Krabbe Disease Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Krabbe Disease Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Krabbe Disease Drugs Market Share by Region (2016-2027)
Figure 40. China Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Krabbe Disease Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Krabbe Disease Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Krabbe Disease Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Krabbe Disease Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Krabbe Disease Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Krabbe Disease Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Krabbe Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Krabbe Disease Drugs Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Krabbe Disease Drugs Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Krabbe Disease Drugs Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Krabbe Disease Drugs Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Krabbe Disease Drugs Business (2016-2021)
Figure 64. Abbott Laboratories Revenue Growth Rate in Krabbe Disease Drugs Business (2016-2021)
Figure 65. Teva Pharmaceutical Revenue Growth Rate in Krabbe Disease Drugs Business (2016-2021)
Figure 66. Takeda Revenue Growth Rate in Krabbe Disease Drugs Business (2016-2021)
Figure 67. UCB Pharmaceuticals Revenue Growth Rate in Krabbe Disease Drugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---